Neuralink is a neurotechnology company founded by Elon Musk in 2016, developing fully implantable, high-bandwidth brain-machine interfaces (BMIs). The company's goal is to create devices that enable direct communication between the brain and computers, with potential applications ranging from treating neurological conditions to enhancing human capabilities.
Neuralink is a neurotechnology company founded by Elon Musk in 2016, developing fully implantable, high-bandwidth brain-machine interfaces (BMIs). The company's goal is to create devices that enable direct communication between the brain and computers, with potential applications ranging from treating neurological conditions to enhancing human capabilities.
Neuralink's core technology consists of:
| Feature | Specification |
|---|---|
| Electrode Count | 1,024 per implant |
| Thread Count | 64 threads |
| Data Bandwidth | ~10 Mbps |
| Battery Life | Rechargeable (inductive charging) |
| Surgery Duration | ~1 hour (robot-assisted) |
Neuralink's initial clinical focus includes Deep Brain Stimulation (DBS)-like functionality for Parkinson's Disease, potentially offering more precise and adaptive stimulation compared to current FDA-approved devices[1].
Neuralink applications for stroke rehabilitation:
For patients with ALS who lose motor function, Neuralink could provide a communication interface that translates neural activity into text or speech[2].
Neuralink for epilepsy management:
Neuralink applications for MS:
The technology may help restore motor function in patients with spinal cord injuries by creating a neural bridge around the injury site.
Neuralink has published preclinical data demonstrating:
Human trials began in 2024, with the first patient receiving the N1 implant in January 2024. Early results announced in 2024 showed the patient was able to control a computer cursor, play video games, and interact with software interfaces using only their thoughts.
The first human trial (PRIME Study) is evaluating:
Patient Noland Arbaugh demonstrated the ability to play chess, navigate the internet, and use productivity software through thought alone. The company has since implanted devices in a second patient.
Neuralink for FTD:
For neurodegenerative diseases, Neuralink offers potential applications in:
Neuralink's technology interfaces with several key neurodegenerative disease mechanisms:
Musk E, Neuralink. An integrated brain-machine interface platform. bioRxiv. 2019. ↩︎
Neuralink Corporation. First-in-human clinical trial protocol. 2024. ↩︎